ArticleJACC. Basic to translational science2020

Lipoprotein(a) Cellular Uptake Ex Vivo and Hepatic Capture In Vivo Is Insensitive to PCSK9 Inhibition With Alirocumab.

Kévin Chemello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.